2Ctech Launches First-Ever Clinical Program to Use Nanoparticles for the Treatment of Retinal Degenerative Diseases
| Date | 24th, Apr 2019 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
2Ctech, Inc., a privately owned development stage company concerned with the application of nanoparticle technologies for the treatment of retinal diseases, announced the launch of the first-ever...